Plasma brain natriuretic peptide, platelet parameters, and cardiopulmonary function in chronic obstructive pulmonary disease

Table 2 Comparison of plasma brain natriuretic peptide and platelet parameters among the pulmonary heart disease, chronic obstructive pulmonary disease, and control groups

Index	PAH group (n = 52)	COPD group (n = 30)	Controls (n = 30)	F	P value
Plasma BNP (pg/L)	59.93 ± 25.77	32.66 ± 6.45a	14.13 ± 2.46a,c	65.484	0.000
PLT (×109/L)	122.93 ± 27.25	161.26 ± 32.25a	198.46 ± 43.69a,c	49.040	0.000
PDW (fL)	19.78 ± 4.96	14.62 ± 2.69a	9.79 ± 1.62a,c	69.027	0.000
PCT (%)	0.17 ± 0.04	0.21 ± 0.05a	0.26 ± 0.04a,c	37.817	0.000
MPV (fL)	19.08 ± 5.21	14.65 ± 3.12a	10.03 ± 2.02a,c	48.422	0.000

^aP < 0.05 vs the pulmonary heart disease group.

^cP < 0.05 vs the chronic obstructive pulmonary disease group.

BNP: Brain natriuretic peptide; COPD: Chronic obstructive pulmonary disease; PLT: Platelet count; PDW: Platelet distribution width; PCT: Plateletcrit; MPV: mean platelet volume.